Evidence map›Paper›PMID 23728808›Full record

ArticleApplied and environmental microbiology2013

Biodegradation of endocrine disruptors in solid-liquid two-phase partitioning systems by enrichment cultures.

Richard Villemur, Silvia Cristina Cunha Dos Santos, Julianne Ouellette, Pierre Juteau, François Lépine, Eric Déziel

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Richard VillemurINRS-Institut Armand-Frappier, Laval, Quebec, Canada.
Silvia Cristina Cunha Dos Santos
Julianne Ouellette
Pierre Juteau
François Lépine
Eric Déziel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Naturally occurring and synthetic estrogens and other molecules from industrial sources strongly contribute to the endocrine disruption of urban wastewater. Because of the presence of these molecules in low but effective concentrations in wastewaters, these endocrine disruptors (EDs) are only partially removed after most wastewater treatments, reflecting the presence of these molecules in rivers in urban areas. The development of a two-phase partitioning bioreactor (TPPB) might be an effective strategy for the removal of EDs from wastewater plant effluents. Here, we describe the establishment of three ED-degrading microbial enrichment cultures adapted to a solid-liquid two-phase partitioning system using Hytrel as the immiscible water phase and loaded with estrone, estradiol, estriol, ethynylestradiol, nonylphenol, and bisphenol A. All molecules except ethynylestradiol were degraded in the enrichment cultures. The bacterial composition of the three enrichment cultures was determined using 16S rRNA gene sequencing and showed sequences affiliated with bacteria associated with the degradation of these compounds, such as Sphingomonadales. One Rhodococcus isolate capable of degrading estrone, estradiol, and estriol was isolated from one enrichment culture. These results highlight the great potential for the development of TPPB for the degradation of highly diluted EDs in water effluents.

Indexed as

Microbial ConsortiaBacteriaBiodegradation, EnvironmentalBioreactorsDenaturing Gradient Gel ElectrophoresisEndocrine DisruptorsGas Chromatography-Mass SpectrometryMolecular Sequence DataPhylogenyPolyestersPolymerase Chain ReactionRNA, Ribosomal, 16SSequence Analysis, DNASequence HomologyWater Pollutants, ChemicalEndocrine DisruptorsHytrelPolyestersRNA, Ribosomal, 16SWater Pollutants, Chemical

Identifiers

PMID23728808
PMCPMC3719513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.